Diaphorina citri psyllid: psy15691


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620
MNDDYDDEQTHRWDQDMVDVDSDGGDDPMENPQEVLNECLEKFSTPDYIMEPGIFSQLKRYFQAGGNPEQVIELLSQNYKAVAQMANLVAEWLILGGVNVTEVQAMVENHLKDMILKTFDPKKADTIFTEEGETPAWLTEMIEHPTWRSLIYRLAEEYPDCLMLNFTIKLISDAGFQREITSISTAAQQIEVFSRVLKTSISNFLESSDDWQSSVEECAKMVCHGQHTYVYSQVLLQVLSLESKGGSKVKRLAQEITKCAQQSGHDVTPIIMALNGAAFYPQANQALSSMISRNSLNPADITVLFRLYSSPDPPPIDLIRIPQFLELLTDSLFKPGVKLNPEHKPKYIYLLAYASSVYEVSTGKKTKQKSFNKDDLKTTIQAIEKVHSICNSSKSSNELIAEITTLFHCIRYPVVSVGVIRWVECTVTEPSYFKLCTEHTPTHLALLDEVVTCHTFLHHKVLQLFIELFESKQDELEILVQLEMRKMLLDRMVNLLCRGCVVPVVKYVKQCWQRGDTDISLIRYFVTEVLEAITPPYTPEFVQLFLPIVENDEITGTMRGDGENDPVSEFIVQTLEHEWHQLEDDKKIYQCWPVHFSSVDFVIEPKGTYGRRITEILTMQ
ccccccHHcccccccccccccccccccccccHHHHHHHHHHHcccccccccccHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHccHHHHHHHHcccccccccHHHHHccHHHHHHHHHHHHHcccccHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHcccccHHHHHHHccccccHHHHHHHHHHHccccccHHHHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHcccccHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHcccccHHHHHHHHHHHHHHccccccHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHcHHHHHHHHHccccccccccEEECccccccccHHHHHccc
************************************NECLEKFSTPDYIMEPGIFSQLKRYFQAGGNPEQVIELLSQNYKAVAQMANLVAEWLILGGVNVTEVQAMVENHLKDMILKTFDPKKADTIFTEEGETPAWLTEMIEHPTWRSLIYRLAEEYPDCLMLNFTIKLISDAGFQREITSISTAAQQIEVFSRVLKTSISNFLESSDDWQSSVEECAKMVCHGQHTYVYSQVLLQVLSLESKGGSKVKRLAQEITKCAQQSGHDVTPIIMALNGAAFYPQANQALSSMISRNSLNPADITVLFRLYSSPDPPPIDLIRIPQFLELLTDSLFKPGVKLNPEHKPKYIYLLAYASSVYEVST***********DDLKTTIQAIEKVHSICNS***SNELIAEITTLFHCIRYPVVSVGVIRWVECTVTEPSYFKLCTEHTPTHLALLDEVVTCHTFLHHKVLQLFIELFESKQDELEILVQLEMRKMLLDRMVNLLCRGCVVPVVKYVKQCWQRGDTDISLIRYFVTEVLEAITPPYTPEFVQLFLPIVENDEITGTMR*****DPVSEFIVQTLEHEWHQLEDDKKIYQCWPVHFSSVDFVIEPKGTYGRRITEILTMQ
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MNDDYDDEQTHRWDQDMVDVDSDGGDDPMENPQEVLNECLEKFSTPDYIMEPGIFSQLKRYFQAGGNPEQVIELLSQNYKAVAQMANLVAEWLILGGVNVTEVQAMVENHLKDMILKTFDPKKADTIFTEEGETPAWLTEMIEHPTWRSLIYRLAEEYPDCLMLNFTIKLISDAGFQREITSISTAAQQIEVFSRVLKTSISNFLESSDDWQSSVEECAKMVCHGQHTYVYSQVLLQVLSLESKGGSKVKRLAQEITKCAQQSGHDVTPIIMALNGAAFYPQANQALSSMISRNSLNPADITVLFRLYSSPDPPPIDLIRIPQFLELLTDSLFKPGVKLNPEHKPKYIYLLAYASSVYEVSTGKKTKQKSFNKDDLKTTIQAIEKVHSICNSSKSSNELIAEITTLFHCIRYPVVSVGVIRWVECTVTEPSYFKLCTEHTPTHLALLDEVVTCHTFLHHKVLQLFIELFESKQDELEILVQLEMRKMLLDRMVNLLCRGCVVPVVKYVKQCWQRGDTDISLIRYFVTEVLEAITPPYTPEFVQLFLPIVENDEITGTMRGDGENDPVSEFIVQTLEHEWHQLEDDKKIYQCWPVHFSSVDFVIEPKGTYGRRITEILTMQ

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Negative elongation factor D Essential component of the NELF complex, a complex that negatively regulates the elongation of transcription by RNA polymerase II by RNA polymerase II. The NELF complex, which acts via an association with the DSIF complex, causes transcriptional pausing.very confidentQ24134
Negative elongation factor C/D Essential component of the NELF complex, a complex that negatively regulates the elongation of transcription by RNA polymerase II. The NELF complex, which acts via an association with the DSIF complex and causes transcriptional pausing, is counteracted by the P-TEFb kinase complex.very confidentQ8IXH7
Negative elongation factor D Essential component of the NELF complex, a complex that negatively regulates the elongation of transcription by RNA polymerase II. The NELF complex, which acts via an association with the DSIF complex and causes transcriptional pausing, is counteracted by the P-TEFb kinase complex.very confidentQ922L6

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0007070 [BP]negative regulation of transcription from RNA polymerase II promoter during mitosisconfidentGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0046021, GO:0010629, GO:0007068, GO:0050789, GO:0010605, GO:0019222, GO:0000122, GO:2000112, GO:2000113, GO:0060255, GO:0010556, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0045896, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0006357, GO:0008150, GO:0010558, GO:0048523
GO:0034244 [BP]negative regulation of transcription elongation from RNA polymerase II promoterconfidentGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:0060255, GO:0006357, GO:0065007, GO:0048519, GO:0010468, GO:0034243, GO:0045934, GO:0019219, GO:0032784, GO:0009889, GO:0032785, GO:0050794, GO:0008150, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0010558, GO:0048523
GO:0003729 [MF]mRNA bindingconfidentGO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:1901363, GO:0003723
GO:0017053 [CC]transcriptional repressor complexconfidentGO:0043234, GO:0044446, GO:0032991, GO:0005575, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0005654, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0044451, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0032021 [CC]NELF complexconfidentGO:0008023, GO:0031974, GO:0043229, GO:0043227, GO:0043226, GO:0005575, GO:0031981, GO:0005634, GO:0005654, GO:0044451, GO:0043234, GO:0032991, GO:0043231, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0070013, GO:0044428, GO:0044424, GO:0044422
GO:0022008 [BP]neurogenesisconfidentGO:0032502, GO:0048856, GO:0044707, GO:0007399, GO:0048869, GO:0030154, GO:0008150, GO:0032501, GO:0044763, GO:0048731, GO:0009987, GO:0007275, GO:0044699
GO:0006368 [BP]transcription elongation from RNA polymerase II promoterprobableGO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0006366, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0044237, GO:0043170, GO:0006354, GO:0006351, GO:0019438
GO:0050434 [BP]positive regulation of viral transcriptionprobableGO:0009893, GO:0019222, GO:0031328, GO:2000243, GO:0031325, GO:2000241, GO:0031323, GO:0050789, GO:0080090, GO:0010604, GO:0009891, GO:0019219, GO:0065007, GO:0046782, GO:0031326, GO:0048518, GO:0045935, GO:0060255, GO:0050792, GO:0009889, GO:0050794, GO:0043902, GO:0043900, GO:0008150, GO:0051171, GO:2001141, GO:0051173, GO:0051252, GO:0051254, GO:0010557, GO:0010556, GO:0048524, GO:0048522
GO:0005515 [MF]protein bindingprobableGO:0003674, GO:0005488
GO:0016032 [BP]viral reproductionprobableGO:0009987, GO:0044764, GO:0008150, GO:0051704

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!